Hbk Investments L P Horizon Therapeutics Public LTD CO Transaction History

Hbk Investments L P

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	N/A	-7,978,967 Closed	0 $0
Q2 2024 Aug 14, 2024	SELL	N/A	-6,050,000 Closed	0 $0
Q4 2023 Feb 14, 2024	SELL	$0.0 - $116.3 $0 - $532 Million	-4,576,000 Closed	0 $0
Q3 2023 Nov 14, 2024	BUY	$98.98 - $115.74 $790 Million - $923 Million	7,978,967 New	7,978,967 $923 Million
Q2 2023 Aug 14, 2024	BUY	$96.34 - $112.38 $583 Million - $680 Million	6,050,000 New	6,050,000 $622 Million
Q1 2023 May 15, 2024	BUY	$107.32 - $113.5 $633 Million - $670 Million	5,900,000 New	5,900,000 $644 Million
Q4 2022 Feb 14, 2024	BUY	$62.39 - $113.8 $285 Million - $521 Million	4,576,000 New	4,576,000 $521 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Hbk Investments L P, based on Form 13F filings with the SEC.

Stay updated on Hbk Investments L P with notifications on news.